These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37101042)

  • 1. [Diabetes mellitus, coronary artery disease and heart disease (Update 2023)].
    Clodi M; Saely CH; Hoppichler F; Resl M; Steinwender C; Stingl H; Wascher TC; Winhofer Y; Sourij H
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):201-206. PubMed ID: 37101042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes mellitus, coronary artery disease und heart disease (Update 2019)].
    Clodi M; Saely CH; Hoppichler F; Resl M; Steinwender C; Stingl H; Wascher TC; Winhofer-Stöckl Y; Sourij H
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):169-173. PubMed ID: 30980152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus, coronary artery disease and heart disease].
    Clodi M; Säly C; Hoppichler F; Resl M; Steinwender C; Eber B
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S212-5. PubMed ID: 27052249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
    Circulation; 2013 Aug; 128(8):785-94. PubMed ID: 23857320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial.
    Groenewegen A; Zwartkruis VW; Rienstra M; Zuithoff NPA; Hollander M; Koffijberg H; Oude Wolcherink M; Cramer MJ; van der Schouw YT; Hoes AW; Rutten FH; de Boer RA
    Lancet Public Health; 2024 Feb; 9(2):e88-e99. PubMed ID: 38134944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study.
    Kawabe A; Yasu T; Morimoto T; Tokushige A; Momomura SI; Sakakura K; Node K; Inoue T; Ueda S;
    ESC Heart Fail; 2021 Oct; 8(5):3748-3759. PubMed ID: 34268904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
    Sattar N; McMurray J; Borén J; Rawshani A; Omerovic E; Berg N; Halminen J; Skoglund K; Eliasson B; Gerstein HC; McGuire DK; Bhatt D; Rawshani A
    Circulation; 2023 Jun; 147(25):1872-1886. PubMed ID: 37154040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Artery Calcium Score directed risk stratification of patients with Type-2 diabetes mellitus.
    Nassar M; Nso N; Emmanuel K; Alshamam M; Munira MS; Misra A
    Diabetes Metab Syndr; 2022 Jun; 16(6):102503. PubMed ID: 35653928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes.
    Wolsk E; Claggett B; Diaz R; Dickstein K; Gerstein HC; Køber L; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Pfeffer MA
    J Am Heart Assoc; 2022 Apr; 11(8):e021327. PubMed ID: 35383463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.
    Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nanba Y; Yoshida M; Nakamura K; Morita H; Ito H
    Cardiovasc Diabetol; 2021 Jan; 20(1):8. PubMed ID: 33413363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
    Khawaja T; Linge J; Leinhard OD; Al-Kindi SG; Rajagopalan S; Khera A; de Lemos JA; Joshi P; Neeland IJ
    Prog Cardiovasc Dis; 2023; 78():67-73. PubMed ID: 36931545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    McGuire DK; Alexander JH; Johansen OE; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Kahn SE; Toto RD; Zinman B; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; von Eynatten M; Marx N;
    Circulation; 2019 Jan; 139(3):351-361. PubMed ID: 30586723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.
    Chen J; Budoff MJ; Reilly MP; Yang W; Rosas SE; Rahman M; Zhang X; Roy JA; Lustigova E; Nessel L; Ford V; Raj D; Porter AC; Soliman EZ; Wright JT; Wolf M; He J;
    JAMA Cardiol; 2017 Jun; 2(6):635-643. PubMed ID: 28329057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between gestational diabetes and cardiovascular disease within 24 months postpartum.
    Ackerman-Banks CM; Palmsten K; Lipkind HS; Ahrens KA
    Am J Obstet Gynecol MFM; 2024 Jun; 6(6):101366. PubMed ID: 38580094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically Predicted Type 2 Diabetes Mellitus Liability, Glycated Hemoglobin and Cardiovascular Diseases: A Wide-Angled Mendelian Randomization Study.
    Liu B; Mason AM; Sun L; Di Angelantonio E; Gill D; Burgess S
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter by Tanaka and Node Regarding Article, "Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study".
    Tanaka A; Node K
    Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e007186. PubMed ID: 33435728
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes Mellitus and Long-Term Risk for Heart Failure After Coronary Revascularization.
    Takeji Y; Shiomi H; Morimoto T; Furukawa Y; Ehara N; Nakagawa Y; Kato T; Tazaki J; Kato ET; Yaku H; Yoshikawa Y; Tada T; Hanyu M; Kadota K; Komiya T; Ando K; Kimura T;
    Circ J; 2020 Feb; 84(3):471-478. PubMed ID: 31996490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does coronary artery calcium screening help cardiovascular risk stratification in asymptomatic young patients with diabetes mellitus? A knowledge gap.
    Carbone A; Baliga RR; Cademartiri F; Bossone E
    Eur J Prev Cardiol; 2024 Apr; 31(6):742-743. PubMed ID: 38445756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.